Investing
Allergan, Newell Brands Topple into Thursday's 52-Week Low Club
Published:
Last Updated:
October 19, 2017: Here are four stocks trading with heavy volume among 13 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by about 8 to 7 and on the Nasdaq decliners led advancers by about 3 to 2.
Allergan plc (NYSE: AGN) dropped about 3.2% Thursday to post a new 52-week low of $182.80 after closing at $187.15 on Wednesday. The 52-week high is $256.80. Volume was around 86.5 million, more than double the daily average of about 2.6 million. The company’s blockbuster eye drug may see a generic competitor as early as next year.
Immune Pharmaceuticals Inc. (NASDAQ: IMNP) dropped about 64% Thursday to post a new 52-week low of $0.88 after closing at $1.52 on Wednesday. The 52-week high is $5.02. Volume was around 5.7 million, approaching six times the daily average. The company priced a convertible offering this morning at $1.10 per share, making investors very unhappy.
Newell Brands Inc. (NYSE: NWL) dropped about 1.9% Thursday to post a new 52-week low of $40.44 after closing at $41.21 on Wednesday. The stock’s 52-week high is $55.08. Volume of around 5.2 million was about 15% above the daily average. The company had no specific news.
Sally Beauty Holdings Inc. (NYSE: SBH) posted a new 52-week low of $16.36 on Thursday, down about 7.8% from Wednesday’s closing price of $17.75. The stock’s 52-week high is $30.17. Volume totaled around 5 million shares, more than double the daily average. The company had no specific news.
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.